To assess the dependency on T cells for the therapeutic effect of aCD40 in ERα + tumors, tumor-bearing control and treated mice were depleted of CD8 + or CD4 + or both CD4 + and CD8 + T cells (Suppl. The gene discussed is CD4; the disease is neoplasm.